Clinical Research – An Emerging Career

Take your first step into Clinical Research Industry. Click here
www.crocareers.in

Clinical Trials : Why India is irresistable?

'Global consultancy McKinsey & Co estimates that by 2010, global
pharma majors would spend around $1-1.5 billion just for drug trials
in the country.'

http://www.rediff.com/money/2004/dec/22spec.htm

Join the 6 part Free Foundation course in Clinical Research now!
www.crocareers.in The free course will give you a brief overview of
the clinical research industry and also the topics that will be
covered in the full CCRP course.

An estimated 100,000+ clinical trials are carried out throughout the
world. Thousands of trials are conducted in India.

Eligibility: B.Pharm, M.Pharm, MBBS, MD, BDS, MDS, BPT, MPT, BAMS,
BHMS, B.Sc , M.Sc ( Nursing, Microbiology, Biotechnology, Lab science,
Genetics, Nutrition, Botany, Zoology ). Rewarding career opportunities
in CROs (Contract Research Organizations), Pharmaceutical companies,
Hospitals and biotech companies.

CCRP course is strengthened with 4 modules tailored to meet the
industry needs. The timeframe for the course is 12 weeks. This course
syllabus would help you get better equipped with the fundamentals and,
inturn, throw open more clinical research career opportunities at you.

Join the 6 part Free Foundation course in Clinical Research now!
www.crocareers.in

Mail us at [EMAIL PROTECTED] for more details






--~--~---------~--~----~------------~-------~--~----~
Join Biofriend New forum to reduce email load.
post your questions on new blog 

http://cbclickbank.com/biofriend/ 
Please visit this link & send your friends too
=========================================
http://www.cbclickbank.com/bioinformatics/company.htm
Read message on web -  Subject -  " No email " &  email us 
Remove from group  -  Subject  - " unsubscribe me " &  email us
for more information visit 
http://www.cbclickbank.com/bioinformatics/giudence.htm

We assure that your query we would answer within 24 Hrs. 
post message send email - [email protected]
-~----------~----~----~----~------~----~------~--~---

Reply via email to